Bentham Science Logo

Track Your Manuscript:


Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 20, 4 Issues, 2020
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Drug Targets - Cardiovascular & Hematological Disorders, Volume 5 - Number 3



Modulating Alloimmune Responses with Plasmapheresis and IVIG

, 5(3): 215 - 222

Daniel S. Warren, Christopher E. Simpkins, Matthew Cooper and Robert A. Montgomery


DOI: 10.2174/1568006054064735







Editor-in-Chief

Garry X. Shen
University of Manitoba
Winnipeg, MB
(Canada)
Biography
View Full Editorial Board

COPE Compliant

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.46

New eBook

Frontiers in Clinical Drug Research-Hematology



You can view the contents of this eBook [here] or purchase it [here].

Advertisement

Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog